title: Salmeterol and Fluticasone Propionate in Children with Asthma.
authors.affiliation: GlaxoSmithKline, Research Triangle Park, NC
  david.a.stempel@gsk.com
authors.forename: David A
authors.initials: DA
authors.lastname: Stempel
authors.affiliation: University of Colorado School of Medicine, Aurora, CO
authors.forename: Stanley J
authors.initials: SJ
authors.lastname: Szefler
authors.affiliation: GlaxoSmithKline, King of Prussia, PA
authors.forename: Steven J
authors.initials: SJ
authors.lastname: Pascoe
mesh_terms: D000280:Administration, Inhalation; D000420:Albuterol / Q000627:therapeutic use; D000730:Androstadienes / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002648:Child; D004338:Drug Combinations; D000068298:Fluticasone; D006801:Humans; D000068299:Salmeterol Xinafoate
chemical_list: D000730:Androstadienes; D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents; D004338:Drug Combinations; D000068299:Salmeterol Xinafoate; D000068298:Fluticasone; D000420:Albuterol